Find uplifting stories about heroes, innovations, and solutions
6719 results for "hiv prevention kenya"
Kenya began administering a groundbreaking HIV prevention injection that's taken just twice a year and reduces transmission risk by more than 99.9 percent. The drug is free for recipients, offering new hope to 1.3 million Kenyans living with HIV.
Kenya just became one of the first countries to roll out a groundbreaking HIV prevention drug that requires just two shots per year. The new treatment could transform how millions protect themselves from the virus.
Kenya just became one of the first countries to offer a groundbreaking HIV prevention drug that requires just two injections per year, completely free to those who need it most. The move brings new hope to 1.4 million Kenyans living with HIV and vulnerable young people facing the highest risk of infection.
Kenya just became one of the first countries to offer a groundbreaking HIV prevention injection that protects people for six months with a single shot. The treatment is completely free and could change the lives of 1.4 million Kenyans living with HIV.
Kenya just became one of the first countries in the world to offer a revolutionary HIV prevention drug that only requires two shots per year. The free injectable could protect millions and dramatically reduce new infections across the nation.
Kenya just received its first shipment of Lenacapavir, a groundbreaking HIV prevention treatment that requires just two injections per year instead of daily pills. The new option could dramatically reduce infections among pregnant and breastfeeding women, who face the highest risk.
Kenya just became one of the first countries to offer a groundbreaking HIV prevention injection that works for six months with a single shot. The innovation could protect millions of young people and women who face the highest risk.
Kenya just received its first shipment of a groundbreaking HIV prevention drug that only requires two injections per year. The game-changing medication will reach high-risk communities starting in March at a fraction of its former cost.
Kenya becomes the first country to roll out Lenacapavir, a groundbreaking injection that prevents HIV for six months with a single shot. The breakthrough could dramatically reduce the country's 20,000 annual new infections by eliminating daily pill routines.
A groundbreaking trial in rural Kenya and Uganda slashed new HIV infections by 70% using community health workers, smartphones, and existing medications. The success proves that closing the gap between available treatments and people who need them can dramatically reduce infections.
Patient advocates from 30 countries are already calling on Merck to ensure its promising monthly HIV prevention pill reaches everyone who needs it. The treatment could revolutionize HIV prevention by replacing daily pills with a once-a-month option.
Nigeria will introduce a twice-yearly HIV prevention injection in March 2026 that's 99.9% effective and costs just $40 per year. The breakthrough drug could transform HIV prevention for 1.9 million Nigerians living with the virus.
South Africa just received its first shipment of a revolutionary HIV prevention medication that requires just two shots per year. In a country where 8.15 million people live with HIV, this could transform prevention efforts.
A promising HIV prevention pill could be manufactured for less than $5 per patient annually, making protection accessible to millions worldwide. The experimental drug shows results within 24 hours and could transform HIV prevention in low-income countries.
A twice-yearly injection called Lenacapavir prevented HIV transmission with near-perfect results across two major trials involving 8,200 people in high-risk areas. The breakthrough could transform HIV prevention by replacing daily pills with just two shots per year.
Mozambique just became one of the first African nations to offer lenacapavir, a groundbreaking HIV prevention injection that's 99% effective and only needs two doses per year. The new option could be life-changing for the 92,000 people who contracted HIV in the country last year.
A twice-yearly injection prevented every single HIV infection in a major clinical trial, offering new hope for Nigeria's 1.9 million people living with HIV. The challenge now is making this breakthrough affordable and accessible to those who need it most.
Nigeria will receive a groundbreaking HIV prevention injection that works for six months with just two doses per year, making protection more accessible than ever. The new drug arrives in March 2026 as part of the country's ambitious plan to end the HIV epidemic.
South Africa is partnering with Gilead Sciences to manufacture a revolutionary HIV prevention medicine that requires just two injections per year. The deal could bring affordable access to a drug that offers near-complete protection against HIV infection.
Uganda is rolling out a revolutionary HIV prevention injection that only needs to be taken twice a year, starting with three districts including Kazo. The breakthrough could solve the biggest challenge with daily prevention pills: people simply forgetting to take them.
Showing 20 of 6719